These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 38239345)

  • 1. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets.
    Li L; Lu J; Liu J; Wu J; Zhang X; Meng Y; Wu X; Tai Z; Zhu Q; Chen Z
    Front Immunol; 2023; 14():1340677. PubMed ID: 38239345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory loops in the epithelial-immune microenvironment of the skin and skin appendages in chronic inflammatory diseases.
    Dainichi T; Iwata M
    Front Immunol; 2023; 14():1274270. PubMed ID: 37841246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis.
    Chen Y; Tai Z; Zhu C; Yu Q; Zhu Q; Chen Z
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies.
    Xu J; Chen H; Qian H; Wang F; Xu Y
    J Nanobiotechnology; 2022 Oct; 20(1):448. PubMed ID: 36242051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits.
    Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Avitabile D; Albanesi C; Madonna S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis.
    Dainichi T; Kitoh A; Otsuka A; Nakajima S; Nomura T; Kaplan DH; Kabashima K
    Nat Immunol; 2018 Dec; 19(12):1286-1298. PubMed ID: 30446754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Inflammatory Response in Psoriasis: a Comprehensive Review.
    Deng Y; Chang C; Lu Q
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):377-89. PubMed ID: 27025861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for psoriasis: A journey from classical to advanced therapies. How far have we reached?
    Hari G; Kishore A; Karkala SRP
    Eur J Pharmacol; 2022 Aug; 929():175147. PubMed ID: 35820531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: novel regulators in skin inflammation.
    Sonkoly E; Ståhle M; Pivarcsi A
    Clin Exp Dermatol; 2008 May; 33(3):312-5. PubMed ID: 18419608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of psoriasis and their relevance.
    Nakajima K; Sano S
    J Dermatol; 2018 Mar; 45(3):252-263. PubMed ID: 29226571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological agent exerts therapeutic effects by reversing abnormalities in amino acid metabolic pathways in psoriasis.
    Miao H; Bai Y; Shen S; Chu M; Miao C; Yang J; Li X; Li L; Shao S; Wang G; Dang E
    Exp Dermatol; 2024 Mar; 33(3):e15059. PubMed ID: 38532578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.
    Chamcheu JC; Esnault S; Adhami VM; Noll AL; Banang-Mbeumi S; Roy T; Singh SS; Huang S; Kousoulas KG; Mukhtar H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Control by TRAF6-Mediated Pathways of Epithelial Cells in the EIME (Epithelial Immune Microenvironment).
    Dainichi T; Matsumoto R; Mostafa A; Kabashima K
    Front Immunol; 2019; 10():1107. PubMed ID: 31156649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of subnetworks mediated by [Formula: see text], IL-23/IL-17 and IL-15 in a network involved in the pathogenesis of psoriasis.
    Pandey R; Al-Nuaimi Y; Mishra RK; Spurgeon SK; Goodfellow M
    Sci Rep; 2021 Jan; 11(1):2204. PubMed ID: 33500449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAC1 activation drives pathologic interactions between the epidermis and immune cells.
    Winge MC; Ohyama B; Dey CN; Boxer LM; Li W; Ehsani-Chimeh N; Truong AK; Wu D; Armstrong AW; Makino T; Davidson M; Starcevic D; Kislat A; Nguyen NT; Hashimoto T; Homey B; Khavari PA; Bradley M; Waterman EA; Marinkovich MP
    J Clin Invest; 2016 Jul; 126(7):2661-77. PubMed ID: 27294528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinoctye-neuro-immune-units (KNICUs): collaborative impact on the initiation and maintenance of psoriasis.
    Chen XY; Wang ZY; Zhou Y; Ye LR; Man XY
    Front Med (Lausanne); 2023; 10():1191057. PubMed ID: 37387780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines in psoriasis.
    Baliwag J; Barnes DH; Johnston A
    Cytokine; 2015 Jun; 73(2):342-50. PubMed ID: 25585875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.
    Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Albanesi C; Madonna S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets.
    Gao Y; Gong B; Chen Z; Song J; Xu N; Weng Z
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.